Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
Zanidatamab demonstrated a median overall survival (OS) of 15.5 months in patients with centrally confirmed immunohistochemistry (IHC) 2+ or 3+ and a median OS of 18.1 months in patients with IHC 3+ tumors With approximately two years of median follow-up, as of July 28, 2023, median duration of res
/R E M I N D E R — Media Advisory – Prime Minister’s itinerary for Saturday, June 1, 2024/
OTTAWA, ON, May 31, 2024 /CNW/ – Note: All times local National Capital Region, Canada No public events scheduled This document is also available at https://pm.gc.ca SOURCE Prime Minister’s Office
Duke-NUS’ largest graduating cohort celebrates diverse pathways to medicine
The largest graduating class in Duke-NUS’ history saw 90 graduates, including the first-ever Master of International Translational Medicine cohort, receive their degreesCollectively, this cohort published 99 academic publications, underscoring Duke-NUS’ role as a leader in innovation and
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Chemotherapy
Separate & Distinct from HARMONi-2 Announcement, HARMONi-A Showed Clinically Meaningful and Statistically Significant Benefit: PFS Hazard Ratio of 0.46 For Subset of Patients Previously Receiving 3rd Generation EGFR-TKI: PFS Hazard Ratio of 0.48 5.6% Treatment Discontinuation of Ivonescimab du
ZEEKR Announces May 2024 Delivery Update
HANGZHOU, China, June 1, 2024 /PRNewswire/ — ZEEKR Intelligent Technology Holding Limited (“ZEEKR” or the “Company”) (NYSE: ZK), a fast-growing intelligent battery electric vehicle (“BEV”) technology company, today announced its delivery results for May 202
1 out of every 2 Indian consumers consider Hygiene and assurance of no adulteration while purchasing Milk – Godrej Jersey’s Milk Report
MUMBAI, India, June 1, 2024 /PRNewswire/ — Creamline Dairy Products Limited (CDPL), a subsidiary of India’s largest and diversified agribusiness, Godrej Agrovet Limited (GAVL), recently released a milk report. Titled ‘Bottoms Up…India Says Cheers to Milk,’ it captures cons
ROCKSTAR ENERGY DRINK® AND RUDIMENTAL MARK RETURN OF FRIDAY NIGHT SHOW WITH LEGENDARY PERFORMANCE
Rockstar Energy Drink and UEFA have set the stage for the UEFA Champions League final weekend with a headline performance by Rudimental, powered partly with kinetic energy generated from dancing concert-goers. NEW YORK, June 1, 2024 /PRNewswire/ — Last night, Rockstar Energy Drink® and UEFA,
HTX Ventures Invests in Babylon to Advance Trustless Bitcoin Staking
SINGAPORE, June 1, 2024 /PRNewswire/ — HTX Ventures, the global investment arm of the cryptocurrency exchange HTX, has announced a strategic investment in Babylon, a Bitcoin staking protocol. This investment underlines HTX Ventures’ commitment to fostering innovation and supporting groun
‘A Fu, the hutong gentleman’
BEIJING, June 1, 2024 /PRNewswire/ — A news report from China Daily: Had one never met “A Fu” in person but only heard his standard, fluent Beijing dialect as well as his knowledge of the capital, it would be hard to imagine that he is actually a UK citizen whose real name is Fra
ALL-TIME BEST MONTHLY SALES FOR THE KIA EV9 AND SPORTAGE SUVs LEAD KIA AMERICA TO SECOND BEST SALES MONTH IN COMPANY HISTORY IN MAY
Sales of the all-electric EV9 three-row SUV increased for the second straight month, leading to Kia’s highest EV monthly sales in historySportage, Telluride, Carnival, EV6 and Niro hit all-time sales records in May IRVINE, Calif., June 1, 2024 /PRNewswire/ — On the strength of best-ever